The Precision Oncology Lab is led by School of Medicine researcher Syamantak Khan, PhD. The laboratory's primary focus is understanding how cancer evades various treatments and uses this understanding to innovate precision oncology strategies to address the overarching challenge of therapeutic resistance.
The Precision Oncology Lab is particularly interested in developing novel molecular imaging tools and therapeutic interventions to address heterogeneity and metabolic reprogramming in cancer.
Why Precision Oncology?
No two cancers are the same. Heterogeneity is cancer's weapon for disease progression and evasion from various treatments. To overcome therapeutic resistance in cancer, researchers must accurately model and study the inter-patient and intra-patient tumor heterogeneity. Resistance to drugs and radiotherapy, resulting in disease recurrence, becomes inevitable when cancers are heterogeneous and genetically diverse. Therefore, strategies must be developed to personalize therapy to improve the clinical care of cancer patients.
